Literature DB >> 19397962

Chronic exposure to perfluorododecanoic acid disrupts testicular steroidogenesis and the expression of related genes in male rats.

Zhimin Shi1, Lina Ding, Hongxia Zhang, Yixing Feng, Muqi Xu, Jiayin Dai.   

Abstract

Perfluorododecanoic acid (PFDoA), a synthetic perfluorinated chemical, has been detected in environmental matrices, wildlife, and human serum. Its potential health risk for humans and animals has raised public concern. However, the effects of chronic PFDoA exposure on male reproduction remain unknown. The aim of this study was to determine the effects of chronic PFDoA exposure (110 days) on testosterone biosynthesis and the expression of genes related to steroidogenesis in male rats. In this study, we examined the serum levels of sex hormones, growth hormone, and insulin in male rats. Testicular morphology and the expression of key genes and proteins in testosterone biosynthesis were also analyzed. Markedly decreased serum testosterone levels were recorded after 110 days of PFDoA exposure at 0.2mg PFDoA/kg/day and 0.5mg PFDoA/kg/day, and cast-off cells were observed in some seminiferous tubules in testes exposed to 0.5mg PFDoA/kg/day. PFDoA exposure resulted in significantly decreased protein levels of steroidogenic acute regulatory protein (StAR) and cholesterol side-chain cleavage enzyme (P450scc), along with significantly reduced mRNA levels of insulin-like growth factor I (IGF-I), insulin-like growth factor I receptor (IGF-IR), and interleukin 1alpha (IL-1alpha) in rat testes at 0.2mg/kg/day and 0.5mg/kg/day. In addition, PFDoA exposure also affected the expression of some genes in the hypothalamo-neurohypophyseal system. However, PFDoA did not affect the expression of 5alpha-reductase, 3alpha-hydroxysteroid dehydrogenase, or aromatase in testis and liver. These findings demonstrate that chronic PFDoA exposure disrupts testicular steroidogenesis and expression of related genes in male rats. Multiple factors may be involved in the inhibition of testosterone by PFDoA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19397962     DOI: 10.1016/j.toxlet.2009.04.014

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  6 in total

1.  Endocrine disrupting chemicals: Multiple effects on testicular signaling and spermatogenesis.

Authors:  Bonnie Hy Yeung; Hin T Wan; Alice Ys Law; Chris Kc Wong
Journal:  Spermatogenesis       Date:  2011-07-01

2.  Designing Endocrine Disruption Out of the Next Generation of Chemicals.

Authors:  T T Schug; R Abagyan; B Blumberg; T J Collins; D Crews; P L DeFur; S M Dickerson; T M Edwards; A C Gore; L J Guillette; T Hayes; J J Heindel; A Moores; H B Patisaul; T L Tal; K A Thayer; L N Vandenberg; J Warner; C S Watson; F S Vom Saal; R T Zoeller; K P O'Brien; J P Myers
Journal:  Green Chem       Date:  2013-01       Impact factor: 10.182

3.  Implications of early menopause in women exposed to perfluorocarbons.

Authors:  Sarah S Knox; Timothy Jackson; Beth Javins; Stephanie J Frisbee; Anoop Shankar; Alan M Ducatman
Journal:  J Clin Endocrinol Metab       Date:  2011-03-16       Impact factor: 5.958

Review 4.  Targeting testis-specific proteins to inhibit spermatogenesis: lesson from endocrine disrupting chemicals.

Authors:  H T Wan; Dolores D Mruk; Chris K C Wong; C Yan Cheng
Journal:  Expert Opin Ther Targets       Date:  2013-04-22       Impact factor: 6.902

5.  Hypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice.

Authors:  Sandra L Rebholz; Thomas Jones; Robert L Herrick; Changchun Xie; Antonia M Calafat; Susan M Pinney; Laura A Woollett
Journal:  Toxicol Rep       Date:  2016

6.  Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.

Authors:  Naila Khalil; Aimin Chen; Miryoung Lee; Stefan A Czerwinski; James R Ebert; Jamie C DeWitt; Kurunthachalam Kannan
Journal:  Environ Health Perspect       Date:  2015-06-09       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.